ProKidney Corp.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 22.9% | – | – | – | -2,263.2% | – | – | 644.2% | 644.0% | 635.0% | – | – | |
| – | 77.1% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | -544.0% | -535.0% | 100.0% | -252.6% | |
| – | 501.3% | – | – | – | 52,343.4% | 11,853.5% | 11,711.3% | 12,359.9% | 15,180.9% | 14,974.3% | 24,063.3% | 16,004.3% | |
| – | 37.4% | – | – | – | 15,613.2% | 6,241.3% | 6,356.6% | 5,500.0% | 2,784.0% | 5,007.5% | 8,285.3% | 5,127.6% | |
| – | 538.7% | – | – | – | 67,956.6% | 18,094.8% | 18,067.9% | 17,859.9% | 19,620.9% | 19,346.9% | 32,348.7% | 21,412.0% | |
| – | -538.7% | – | – | – | -67,856.6% | -17,994.8% | -17,967.9% | -17,759.9% | -20,164.9% | -19,881.9% | -32,248.7% | -21,664.5% | |
| – | 0.1% | – | – | – | 2.6% | 0.0% | 0.5% | 0.9% | 0.4% | 6.6% | 0.7% | 2.3% | |
| – | -421.3% | – | – | – | -61,553.9% | -16,243.9% | -16,342.5% | -16,259.4% | -18,860.9% | -18,858.8% | -30,957.3% | -20,388.4% | |
| – | 62.1% | – | – | – | 2,239.5% | 257.0% | 383.7% | 258.1% | -704.4% | -8,865.9% | -18,948.0% | -6,049.4% | |
| – | -126.9% | – | – | – | -27,997.4% | -7,275.7% | -7,489.6% | -7,589.4% | -8,547.1% | -9,992.9% | -18,948.0% | -10,599.8% | |
| – | -395.7% | – | – | – | -59,480.3% | -15,548.3% | -15,679.2% | -15,487.6% | -18,216.4% | -18,217.3% | -29,990.7% | -19,651.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.